GS18 Polypeptide for Bone Repair via Wnt Pathway Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for bone repair, such as autologous and allogeneic bone transplantation, and bone tissue engineering, face limitations including donor site morbidity, resource constraints, ethical concerns, and adverse effects from existing osteogenic agents like PTH and BMP2, necessitating a safer and more effective agent for promoting bone regeneration.
Innovation Solution
An artificially synthesized 18-amino acid polypeptide, GS18, with the sequence GPGGDKCRCVFHWVCCYVS, is developed for bone repair, which can be synthesized using conventional methods and incorporated into tissue engineering scaffolds to activate β-catenin nuclear translocation and promote osteocalcin expression, thereby facilitating bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous bone transplantation is used to repair bone defects, then bone repair effectiveness is improved, but donor site morbidity and lack of donor sources occur
Solution Approach 1:
The patent uses a synthetic peptide (GS18) that copies the osteoinductive function of natural bone morphogenetic proteins. Instead of transplanting actual bone tissue, the invention creates a molecular copy of the key signaling sequence that triggers bone formation, thereby achieving bone repair without donor site morbidity
Solution Approach 2:
The invention extracts the essential osteoinductive signaling function from complex bone tissue and isolates it into a specific 18-amino acid peptide sequence (GS18). This extracted peptide can be synthesized artificially and applied directly to bone defects, separating the therapeutic function from the need for donor bone tissue
2Reliability
If allogeneic bone transplantation is used to address donor source limitations, then bone repair capability is improved, but resource constraints and ethical considerations arise
Solution Approach 1:
The patent employs a synthetic peptide that can be produced through chemical synthesis rather than requiring harvested bone tissue. This disposable, artificially synthesized peptide can be manufactured on demand without depleting donor sources, making the treatment more accessible and eliminating ethical concerns associated with bone harvesting
Solution Approach 2:
The invention changes the fundamental parameter of treatment delivery from biological tissue transplantation to synthetic peptide application. This parameter change transforms the resource constraint from limited donor bone supplies to scalable chemical synthesis, dramatically improving resource availability
3Reliability
If parathyroid hormone (PTH) is used to promote new bone formation, then osteogenesis is improved, but osteosarcoma risk increases at high doses
Solution Approach 1:
The patent applies the osteoinductive effect locally at the bone defect site through direct application of the GS18 peptide to the wound bed. This localized delivery achieves high concentration where needed for bone formation while avoiding systemic circulation that would expose other tissues to carcinogenic risks associated with high-dose PTH
4Reliability
If bone morphogenetic protein (BMP2) is used to stimulate bone regeneration, then bone formation is improved, but short half-life and ectopic bone formation occur
Solution Approach 1:
The patent changes the molecular structure from full-length BMP2 protein to a truncated 18-amino acid peptide sequence (GS18) that retains osteoinductive activity. This structural parameter change increases stability and extends half-life while reducing the complexity that leads to ectopic bone formation
Solution Approach 2:
The invention extracts only the critical osteoinductive signaling domain from the full BMP2 protein, creating a minimal peptide version. This extracted sequence maintains the essential bone-forming function while eliminating portions of the protein that contribute to short half-life and off-target effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
GS18 effectively promotes osteogenesis, recruits cells into bone defects, and accelerates bone repair by activating the Wnt/β-catenin pathway, demonstrating potential as a safe and efficient therapeutic agent for bone tissue engineering, with low immunogenicity and rapid tissue absorption.
Implementation Method 1
activate β-catenin nuclear translocation and promote osteocalcin expression
Implementation Method 2
activating the Wnt/β-catenin pathway
Implementation Method 3
promote osteogenesis, recruits cells into bone defects, and accelerates bone repair
Implementation Method 4
facilitating bone regeneration
Data Source
AI summary
A polypeptide and an application thereof in bone repair are provided. An amino acid sequence of the polypeptide provided by the invention is shown as SEQ ID NO: 1. The invention further discloses use of the polypeptide GS18 in bone injury and/or bone repair. Furthermore, the invention further discloses an application of the polypeptide GS18 as well as a polypeptide scaffold for bone repair. The polypeptide of the invention demonstrates the ability to translocate β-catenin into the nucleus and induce the expression of secreted protein osteocalcin in vivo. In vitro, the polypeptide facilitates the osteogenic differentiation of osteogenesis-oriented BMSCs (pre-osteoblasts thereby promoting the process of bone repair.